Literature DB >> 16954215

Crystal structure of thrombin in a self-inhibited conformation.

Agustin O Pineda1, Zhi-Wei Chen, Alaji Bah, Laura C Garvey, F Scott Mathews, Enrico Di Cera.   

Abstract

The activating effect of Na(+) on thrombin is allosteric and depends on the conformational transition from a low activity Na(+)-free (slow) form to a high activity Na(+)-bound (fast) form. The structures of these active forms have been solved. Recent structures of thrombin obtained in the absence of Na(+) have also documented inactive conformations that presumably exist in equilibrium with the active slow form. The validity of these inactive slow form structures, however, is called into question by the presence of packing interactions involving the Na(+) site and the active site regions. Here, we report a 1.87A resolution structure of thrombin in the absence of inhibitors and salts with a single molecule in the asymmetric unit and devoid of significant packing interactions in regions involved in the allosteric slow --> fast transition. The structure shows an unprecedented self-inhibited conformation where Trp-215 and Arg-221a relocate >10A to occlude the active site and the primary specificity pocket, and the guanidinium group of Arg-187 penetrates the protein core to fill the empty Na(+)-binding site. The extreme mobility of Trp-215 was investigated further with the W215P mutation. Remarkably, the mutation significantly compromises cleavage of the anticoagulant protein C but has no effect on the hydrolysis of fibrinogen and PAR1. These findings demonstrate that thrombin may assume an inactive conformation in the absence of Na(+) and that its procoagulant and anticoagulant activities are closely linked to the mobility of residue 215.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954215     DOI: 10.1074/jbc.M605530200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Conformational selection in trypsin-like proteases.

Authors:  Nicola Pozzi; Austin D Vogt; David W Gohara; Enrico Di Cera
Journal:  Curr Opin Struct Biol       Date:  2012-06-03       Impact factor: 6.809

2.  Crystal structure of prethrombin-1.

Authors:  Zhiwei Chen; Leslie A Pelc; Enrico Di Cera
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

3.  Structural identification of the pathway of long-range communication in an allosteric enzyme.

Authors:  Prafull S Gandhi; Zhiwei Chen; F Scott Mathews; Enrico Di Cera
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

4.  Stabilization of the E* form turns thrombin into an anticoagulant.

Authors:  Alaji Bah; Christopher J Carrell; Zhiwei Chen; Prafull S Gandhi; Enrico Di Cera
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

5.  Mechanism of the anticoagulant activity of thrombin mutant W215A/E217A.

Authors:  Prafull S Gandhi; Michael J Page; Zhiwei Chen; Leslie Bush-Pelc; Enrico Di Cera
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

6.  Mutant N143P reveals how Na+ activates thrombin.

Authors:  Weiling Niu; Zhiwei Chen; Leslie A Bush-Pelc; Alaji Bah; Prafull S Gandhi; Enrico Di Cera
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

7.  Structural transitions in ion coordination driven by changes in competition for ligand binding.

Authors:  Sameer Varma; Susan B Rempe
Journal:  J Am Chem Soc       Date:  2008-10-28       Impact factor: 15.419

8.  Impact of mutations on the allosteric conformational equilibrium.

Authors:  Patrick Weinkam; Yao Chi Chen; Jaume Pons; Andrej Sali
Journal:  J Mol Biol       Date:  2012-12-07       Impact factor: 5.469

9.  Na+ binding to meizothrombin desF1.

Authors:  M E Papaconstantinou; P S Gandhi; Z Chen; A Bah; E Di Cera
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

Review 10.  Serine proteases.

Authors:  Enrico Di Cera
Journal:  IUBMB Life       Date:  2009-05       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.